1,25-Dihydroxyvitamin D3: Mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside fromSolanum malacoxylon M. R. HausslerM. R. HughesR. H. Wasserman Section I — Verbal Presentations Pages: 1 - 18
Responses of bone metabolism in the Eel (Anguilla anguilla) to injections of 1,25-dihydroxyvitamin D3 E. LopezJ. Peignoux-DevilleI. Macintyre Section I — Verbal Presentations Pages: 19 - 23
The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat E. B. MawerA. Reeve Section I — Verbal Presentations Pages: 24 - 28
25-Hydroxyvitamin D3 regulation M. B. ClarkJ. T. Potts Jr. Section I — Verbal Presentations Pages: 29 - 34
Intestinal proteins synthesised in response to vitamin D R. SpencerD. E. M. LawsonM. Charman Section I — Verbal Presentations Pages: 35 - 39
Competitive protein-binding assay for 24,25-dihydroxycholecalciferol C. M. TaylorP. de SilvaS. E. Hughes Section I — Verbal Presentations Pages: 40 - 44
Differences in duodenal calcium-binding protein (CaBP) in response to a low-calcium or a low-phosphorus intake M. ThomassetP. Cuisinier-GleizesH. Mathieu Section I — Verbal Presentations Pages: 45 - 50
The effects of dietary calcium and of oestrogen on the metabolism of 25-hydroxycholecalciferol in vitamin D-replete chicks B. A. SommervilleR. SwaminathanC. G. Scanes Section I — Verbal Presentations Pages: 51 - 54
Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1α-hydroxy vitaminD3 M. PeacockP. J. HeyburnJ. E. Aaron Section I — Verbal Presentations Pages: 55 - 62
Treatment of the rickets of cystinosis with 1-alpha-hydroxycholecalciferol J. M. GertnerD. P. BrentonM. Domenech Section I — Verbal Presentations Pages: 63 - 67
Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism M. Davies Section I — Verbal Presentations Pages: 68 - 73
Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in osteoporosis M. DaviesE. B. MawerP. H. Adams Section I — Verbal Presentations Pages: 74 - 77
The effect of 1α-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis D. H. MarshallJ. C. GallagherB. E. C. Nordin Section I — Verbal Presentations Pages: 78 - 84
Serum ionized calcium in renal failure — a guideline for 1α-hydroxycholecalciferol treatment S. Pors NielsenT. Falck ChristiansenO. H. Sørensen Section I — Verbal Presentations Pages: 85 - 93
Treatment of renal osteodystrophy with 1α-hydroxycholecalciferol (1α-OH-D3) in conjunction with a high dialysate calcium R. J. WinneyJ. M. BoneJ. S. Robson Section I — Verbal Presentations Pages: 94 - 100
Controlled therapeutic trial of 1α-hydroxycholecalciferol in chronic renal failure L. TougaardE. SörensenA. W. S. Sörensen Section I — Verbal Presentations Pages: 101 - 104
1α-Hydroxycholecalciferol in renal osteodystrophy A. M. PieridesH. A. EllisD. N. S. Kerr Section I — Verbal Presentations Pages: 105 - 111
The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol B. J. R. JunorG. R. D. CattoM. Macleod Section I — Verbal Presentations Pages: 112 - 116
Receptors and cyclic nucleotides in secretion and action of parathyroid hormone G. D. AurbachE. M. BrownS. J. Marx Section I — Verbal Presentations Pages: 117 - 126
Double isotope estimates of intestinal calcium absorptio in rats: Enhancement by parathyroid hormone and 1,25-dihydroxycholecalciferol J. A. ParsonsJ. M. ZanelliR. W. Stevenson Section I — Verbal Presentations Pages: 127 - 132
The role of parathyroid hormone in the adaptation of phosphate absorption from the jejunum of conscious pigs J. FoxR. SwaminathanA. D. Care Section I — Verbal Presentations Pages: 133 - 136
The effect ofβ-blockade on ethanol-induced secretion of calcitonin in chronic renal failure G. HeynenM. CecchettinP. Franchimont Section I — Verbal Presentations Pages: 137 - 141
Physiological hyperparathyroidism in human lactation R. W. RetallackM. JeffriesM. Smith Section I — Verbal Presentations Pages: 142 - 146
The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure J. A. KanisM. EarnshawC. G. Woods Section I — Verbal Presentations Pages: 147 - 153
Calcitonin secretion in renal disease J. C. LeeJ. G. ParthemoreL. J. Deftos Section I — Verbal Presentations Pages: 154 - 157
Studies on the stability of bPTH (1–84) and bPTH (1–34) receptor complexes by measuring the hormone-induced lactate fluxes of embryonic mouse calvariain vitro M. P. M. Herrmann-ErleeJ. W. Hekkelman Section I — Verbal Presentations Pages: 158 - 163
Factors influencing the effect of parathyroid hormone on endosteal cell morphology. A scanning electron microscope study B. KrempienG. FriedrichE. Ritz Section I — Verbal Presentations Pages: 164 - 168
Aerobic glycolysis in bone in the context of membrane-compartmentalization W. F. Neuman Section I — Verbal Presentations Pages: 169 - 178
Initiation of mineral deposition in dentine E. Katchburian Section I — Verbal Presentations Pages: 179 - 184
The fate of matrix proteins during the development of dental enamel C. RobinsonP. FuchsJ. A. Weatherell Section I — Verbal Presentations Pages: 185 - 190
Role of a Ca2+-binding glycoprotein in the calcification process B. De BernardG. FurlanM. Zanetti Section I — Verbal Presentations Pages: 191 - 196
In vitro nucleation of hydroxyapatite by a bone calcium-phospholipid-phosphate complex A. L. BoskeyA. S. Posner Section I — Verbal Presentations Pages: 197 - 201
Biochemical effect of mechanical stress on cultured bone cells A. HarellS. DekelI. Binderman Section I — Verbal Presentations Pages: 202 - 207
Role of ATP and Mg in the stabilization of biological and synthetic amorphous calcium phosphates A. S. PosnerF. BettsN. C. Blumenthal Section I — Verbal Presentations Pages: 208 - 212
Endogenous oestrogen and bone loss following oophorectomy R. LindsayD. M. HartA. Clarke Section I — Verbal Presentations Pages: 213 - 216
Observations of sequential changes in bone mass in postmenopausal women: a controlled trial of oestrogen and calcium therapy A. HorsmanB. E. C. NordinM. Simpson Section I — Verbal Presentations Pages: 217 - 224
Changes in plasma steroids and bone density in Klinefelter's syndrome D. A. S. SmithM. S. Walker Section I — Verbal Presentations Pages: 225 - 228
Interrelationships between bone morphometry, thyroid function tests and serum parathyroid hormone in hyperthyroidism L. MosekildeF. MelsenM. S. Christensen Section I — Verbal Presentations Pages: 229 - 235
The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis V. ParsonsC. J. MitchellR. Hesp Section I — Verbal Presentations Pages: 236 - 240
Bone mineral estimation employing computer-assisted transverse axial tomography I. IsherwoodR. A. RutherfordP. H. Adams Section I — Verbal Presentations Pages: 241 - 241
Quantitative analysis of osteolytic versus osteoclastic activity in various experimental osteoporoses. 1. Disuse osteoporosis G. MarottiM. LeddaM. Fadda Section I — Verbal Presentations Pages: 242 - 246
Autoclasis—a mechanism of bone resorption and an alternative explanation for osteoporosis Jean E. Aaron Section I — Verbal Presentations Pages: 247 - 254
Bone cells and remodelling surfaces in acromegaly G. R. DellingA. Schulz Section I — Verbal Presentations Pages: 255 - 259
Reversibility of osteoporosis induced in adult rats by calcium deficiency. Long- and short-term observations J. A. SevastikoglouV. Th. ThomaidisT. S. Lindholm Section I — Verbal Presentations Pages: 260 - 265
Cells cultured from human giant cell tumors of bone respond to parathyroid hormone S. R. GoldringJ. -M. DayerS. M. Krane Section I — Verbal Presentations Pages: 269 - 274
Long-term culture of parathyroid hormone and prostaglandin E1 responsive bone cells in monolayers and on artificial capillaries J. N. M. HeerscheH. K. MoeL. G. Rao Section I — Verbal Presentations Pages: 275 - 282
Is Paget's disease of bone a viral infection? A. RebelK. MalkaniCh. Bregeon Section I — Verbal Presentations Pages: 283 - 286
